6CW-45076-75378
2 vaccinations
6 coded responses
25 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 450 / OH
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
-
2020-12-29
Health check-in — day 0, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-29
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-06
Survey response — day 7, dose 1MedDRA: Dyspnoea — Feeling: Good · Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-12
-
2021-01-20
Survey response — day 21, dose 1MedDRA: Dysgeusia, Taste disorder — Feeling: GoodFree text: Changes in taste (still able to taste, everything just tastes funny).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Dose 2 — Moderna
-
2021-01-26
Health check-in — day 0, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling, Itching · Headache, Joint painsAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Headache, DiarrheaAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-11
-
2021-02-16
Survey response — day 21, dose 2MedDRA: Pityriasis rosea, Rash, Unevaluable event — Feeling: GoodFree text: Skin rash that looks like pityriasis rosea-has not been diagnosed.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — day 28, dose 2MedDRA: Pityriasis rosea — Feeling: GoodFree text: Worsening pityriasis roseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
-
2021-03-11
Survey response — day 42, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Worsening pityriasis roseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-29
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I got covidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-27
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-29 | priority 2/3 | |
| 2020-12-30 | priority 2/3 | |
| 2022-01-26 | Successful 2022-01-27 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Shortness of breath
Release 2 — day 21, dose 1
Symptoms: Changes in taste (still able to taste, everything just tastes funny).
Release 4 — day 21, dose 2
Symptoms: Skin rash that looks like pityriasis rosea-has not been diagnosed.
Release 4 — day 28, dose 2
Symptoms: Worsening pityriasis rosea
Release 5 — day 42, dose 2
Symptoms: Worsening pityriasis rosea
Release 11 — 12 months, dose 2
Symptoms: I got covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dysgeusia | ✓ | ✓ | ✓ |
| SD | Pityriasis rosea | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Taste disorder | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ○ | ✓ | ○ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release